Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 24:35:e1661.
doi: 10.1590/0102-672020210002e1661. eCollection 2022.

THE ESOPHAGEAL, GASTRIC, AND COLORECTAL TUMORS AND THE ESOPHAGOGASTRODUODENOSCOPIES AND COLONOSCOPIES BY THE BRAZILIAN UNIFIED HEALTH SYSTEM: WHAT IS THE IMPORTANCE?

Marilisa Ferruda Andreoli Risso  1 , Luigi Carlo da Silva Costa  1 , Valdir Tercioti Jr  2 , José Antonio Possatto Ferrer  1   2 , Luiz Roberto Lopes  1   2 , Nelson Adami Andreollo  1   2
Affiliations

THE ESOPHAGEAL, GASTRIC, AND COLORECTAL TUMORS AND THE ESOPHAGOGASTRODUODENOSCOPIES AND COLONOSCOPIES BY THE BRAZILIAN UNIFIED HEALTH SYSTEM: WHAT IS THE IMPORTANCE?

Marilisa Ferruda Andreoli Risso et al. Arq Bras Cir Dig. .

Abstract
in English, Portuguese

Aim: Esophagogastroduodenoscopies and colonoscopies are the main diagnostic examinations for esophageal, stomach, and colorectal tumors. This study aimed to evaluate the estimates of the incidence of esophageal, stomach, and colorectal cancer; population growth; and esophagogastroduodenoscopies and colonoscopies performed by the Unified Health System (SUS), from 2010 to 2018, in the five regions of the country, and to analyze the relationship between these values.

Results: The colorectal tumor had a significant elevation, while the esophageal and gastric maintained the incidences. In the five regions, there was a significant increase in the number of colonoscopies; however, this increase did not follow the increase in the population in the North and Northeast regions. There was no significant increase in the number of esophagogastroduodenoscopies in the North, Northeast, Midwest, and South regions, and in the North region there was a decrease. In the Northeast region, there was a decreasing number, and in the South and Midwest regions, the number of examinations remained stable in the period. The Southeast region recorded an increase in the number of examinations following the population growth.

Conclusion: The current number of esophagogastroduodenoscopies and colonoscopies performed by the SUS did not follow the population growth, in order to attend the population and diagnose esophageal, stomach, and colorectal tumors. Therefore, the country needs to have adequate and strategic planning on how it will meet the demand for these tests and serve the population well, incorporating new technologies.

Os tumores de esôfago, estômago e colorretal têm como principal exame diagnóstico as esofagogastroduodenoscopias e colonoscopias.

OBJETIVO:: Avaliar as estimativas de incidências de câncer de esôfago, estômago e colorretal, o crescimento populacional, e as esofagogastroduodenoscopias e colonoscopias realizadas pelo Sistema Único de Saúde (SUS) de 2010 a 2018, nas cinco regiões do país e a relação entre esses valores.

RESULTADOS:: O tumor colorretal teve elevação significativa, enquanto os esofágicos e gástricos mantiveram as incidências. Nas cinco regiões foi registrado elevação significativa do número de colonoscopias, entretanto, essa elevação não acompanhou a elevação da população nas regiões Norte e Nordeste. Não ocorreu elevação significativa do número de esofagogastroduodenoscopias nas regiões Norte, Nordeste, Centro-Oeste e Sul e na região Norte ocorreu diminuição. Na região Nordeste ocorreu número decrescente e nas regiões Sul e Centro-Oeste o número de exames manteve-se estável no período. A região Sudeste registrou elevação do número de exames acompanhando o crescimento população.

CONCLUSÃO:: O número atual de esofagogastroduodenoscopias e colonoscopias realizadas pelo SUS, não acompanhou o crescimento populacional, para atender a população e diagnosticar os tumores de esôfago, estômago e colorretais. Portanto, o país necessita ter um planejamento adequado e estratégico de como irá suprir a demanda desses exames e bem atender a população, incorporando as novas tecnologias.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none

Figures

Figure 1 -
Figure 1 -. Evolution of the population living in the North and of endoscopic examinations in the same region.
Figure 2 -
Figure 2 -. Evolution of the population living in the Northeast region and of endoscopic examinations in the same region.
Figure 3 -
Figure 3 -. Evolution of the population living in the Southeast region and of endoscopic examinations in the same region.
Figure 4 -
Figure 4 -. Evolution of the population living in the South and of endoscopic examinations in the same region.
Figure 5 -
Figure 5 -. Evolution of the population living in the Midwest region and of endoscopic examinations in the same region.
Figure 6 -
Figure 6 -. Evolution of the number of esophageal, stomach, and colorectal cancer in the country, from 2010 to 2018.
See this image and copyright information in PMC

References

    1. Barchi LC, Ramos MFKP, Yagi OK, Mucerino DR, Bresciani CJC, Ribeiro U, JÚnior, et al. Brazilian Gastric Cancer Association guidelines (part 1): an update on diagnosis, staging, endoscopic treatment and follow-up. Arq Bras Cir Dig. 2020;33(3):e1535. doi: 10.1590/0102-672020200003e1535. - DOI - PMC - PubMed
    1. Box G. E. P., Jenkins G. M. Time Series Analysis: Forecasting and Control. San Francisco: Holden Day; 1976.
    1. Brasil Ministério da Saúde, Datasus, Produção Ambulatorial do SUS-Brasil. http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sia/cnv/qauf.def
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020;70(4):313. - DOI - PubMed
    1. Cardoso DMM, Botacin MAS, Mekdessi MA. Adenoma detection rate evaluation and quality of colonoscopy in the center-west region of Brazil. Arq Gastroenterol. 2017;54(4):315–320. doi: 10.1590/s0004-2803.201700000-47. - DOI - PubMed